IP Library Granted Patent US 7,785,358
Granted Patent B2
US 7,785,358 · App. 11/282,070 · Granted Aug 31, 2010

System and method for tissue treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,785,358
App. No.
11/282,070
Granted
Aug 31, 2010
Kind
B2
Abstract

A system and method for the treatment of body tissue is provided that includes a radiation-emitting device and a massaging mechanism. In accordance with one embodiment, the radiation-emitting device is a laser and the massaging mechanism is an automated mechanical massaging mechanism. The radiation-emitting device can emit radiation in one or both of the visible and infrared wavelengths. The radiation-emitting device can emit radiation in a concentric combination of infrared and visible laser light. The method of using the tissue treatment system includes exposing a skin surface of a patient to radiation emitted from the radiation-emitting device at predetermined wavelengths for predetermined periods of time. The method further provides for massaging the exposed skin surface of the patient with the massaging mechanism. The tissue treatment system can be utilized to effect the reduction of excess cellulite.

Claims (23)

1. A system for treating a condition of a patient, comprising:

a radiation-emitting device for heating tissue of a patient by emitting at least one radiation wavelength in the visible and infrared wavelengths between about 650 nanometers and 1295 nanometers for application to a skin surface of the patient;

a massaging mechanism for massaging the skin surface of the patient treated with the radiation-emitting device for a selected time period; and

a controller mechanism enabled by at least one processor configured to provide emission control of the radiation wavelength;

wherein the controller mechanism is configured to control duration of the radiation emission to treat the condition based at least partially on a measurement of the tissue in an area of the tissue being treated.

2. The system of claim 1 , wherein the radiation-emitting device comprises a laser.

3. The tissue treatment system of claim 1 , wherein the massaging mechanism comprises an automated mechanical massaging mechanism.

4. The system of claim 1 , wherein the radiation-emitting device emits radiation in a concentric combination of infrared radiation and visible radiation.

5. The system of claim 1 , wherein the condition comprises having excess cellulite and treatment of the condition comprises a reduction of the excess cellulite.

6. A method of using a condition treatment system having a radiation-emitting device and a massaging mechanism for treating the condition, the method comprising the steps of:

exposing tissue of a patient to radiation in the visible and infrared wavelengths between about 650 nanometers and 1295 nanometers emitted from the radiation-emitting device for a period of time as controlled by a controller mechanism enabled by at least one processor configured to provide emission control of the radiation; and

massaging a skin surface of the patient proximal to the tissue with the massaging mechanism;

wherein the controller mechanism is configured to control duration of the radiation emission to treat the condition based at least partially on a measurement of the tissue in an area of the tissue being treated.

7. The method according to claim 6 , wherein the step of exposing the tissue comprises applying a laser radiation to the skin surface proximal to the tissue.

8. The method according to claim 7 , wherein the laser radiation applies a concentric combination of infrared and visible laser light to the skin surface.

9. The method according to claim 6 , further comprising the step of exposing the skin surface to an application of infrared radiation.

10. The method according to claim 9 , wherein the application of infrared radiation occurs in a continuous wave.

11. The method according to claim 9 , wherein the application of infrared radiation occurs at predetermined locations corresponding to lymphatic drainage meridians.

12. The method according to claim 9 , wherein the application of infrared radiation heats at least one of deep tissue, tendon, fascia, muscle, and bone within the patient.

13. The method according to claim 6 , wherein the step of massaging the skin surface comprises utilizing a mechanical massage mechanism.

14. The method according to claim 6 , wherein the step of massaging the skin comprises massaging from points distal from a heart of the patient to points proximal to the heart of the patient to encourage fluid flow toward the heart.

15. The method according to claim 6 , wherein the step of massaging the skin comprises massaging in predetermined patterns of motion.

16. The method according to claim 6 , wherein the period of time comprises a range of time between about 5.5 minutes and 12 minutes.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 1, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066723/0227 →
TERMINATION AND RELEASE OF PATENTS Recorded Feb 29, 2024
From: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066707/0957 →
ABL NOTICE AND CONFIRMATION OF GRANT OFSECURITY INTEREST IN PATENTS Recorded Jan 12, 2024
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 066222/0937 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jan 7, 2020
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 051496/0579 →
RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Dec 30, 2019
From: BANK OF AMERICA, N.A.
To: CYNOSURE, LLC
Reel/Frame 051447/0536 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
SECURITY INTEREST Recorded May 3, 2017
From: CYNOSURE, INC.; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 042261/0911 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2011
From: ELEME MEDICAL, INC.
To: CYNOSURE, INC.
Reel/Frame 025783/0465 →
CHANGE OF NAME Recorded Feb 5, 2008
From: BIOCELLULASE, INC.
To: ELEME MEDICAL INC.
Reel/Frame 020468/0352 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2006
From: LACH, ELLIOT
To: BIOCELLULASE, INC.
Reel/Frame 017278/0759 →